In the Columbia-CKD cohort, 279 individuals (10.3%) had a monogenic kidney disorder, defined by a diagnostic finding in any kidney disease gene in Supplemental Table 1, and 130 (4.8%) had high-risk APOL1 genotypes (Table 2 and Supplemental Table 2). This evidence concerns the gene APOL1 and chronic kidney disease.